The Spotlight on Chinese Enterprises series concludes with the spotlight on Sino Biopharmaceutical, a mainland drug manufacturer that hopes to benefit from China's medical reform that would see all mainland citizens covered by medical insurance. The company specialises in producing new medicines that have not been seen on the mainland before. It's been forced by the government to lower some of its prices to make the drugs more affordable, but it expects increased sales by virtue of the fact that its drug are included on the government's list of drugs covered by the medical insurance.